Whoop, Inc. — Cyborg Score 8/10

Strong
Health monitoring wearables

Strategic Profile

In March 2026, Whoop raised $575 million from investors including the Mayo Clinic and Qatar's sovereign wealth fund, valuing the company at $10 billion. The company announced plans to open over 600 new roles throughout 2026 in hardware innovation, research, product development, and global growth. Strategic partnerships include a multi-year deal with the Boston Red Sox starting in 2026.

Cyborg Score Rationale

Whoop's $575 million Series C funding in March 2026 at a $10 billion valuation demonstrates strong investor confidence and competitive positioning. Peer-reviewed research shows members who wear Whoop daily increase weekly exercise by 90+ minutes and improve heart rate variability by 10%. Growth momentum is solid, though competitive pressures from Apple Watch and Fitbit remain.

Top Insights

  • Whoop raised $575 million in March 2026 from Mayo Clinic and Qatar's sovereign wealth fund at a $10 billion valuation, signaling strong healthcare credibility and access to capital for scaling operations globally.
  • The wearable includes an FDA-cleared ECG, Healthspan longevity feature, blood pressure insights, and Advanced Labs blood biomarker analysis, expanding beyond fitness into clinical-grade health monitoring.
  • In March 2026, Whoop announced 600+ new hires across hardware, research, and global growth, reflecting expansion across AI, clinical innovation, and international markets.

Named Competitors

  • Apple Watch — Multi-function smartwatch with fitness and health tracking
  • Fitbit — Fitness tracker and smartwatch with health monitoring
  • Oura Ring — Smart ring for sleep, activity, and recovery tracking
  • Garmin — Sports watch and health tracker with recovery intelligence and training metrics
  • Samsung Galaxy Watch — Smartwatch with sleep staging, stress tracking, and AI health coaching
  • Polar — Sports watch and fitness tracker with recovery and training load monitoring

Recent Developments

  • (March 2026) $575 million Series C funding round at $10 billion valuation with Mayo Clinic and Qatar Investment Authority participation
  • (March 2026) Announced 600+ new hires throughout 2026 in technical, scientific, creative, and commercial roles globally
  • (May 2026) Named Official Health and Fitness Wearable of the Boston Red Sox with multi-year partnership through 2028

Open the full interactive Whoop, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →